Skip to main navigation Skip to search Skip to main content

Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors

  • Xinmin S Li
  • , Slayman Obeid
  • , Roland Klingenberg
  • , Baris Gencer
  • , François Mach
  • , Lorenz Räber
  • , Stephan Windecker
  • , Nicolas Rodondi
  • , David Nanchen
  • , Olivier Muller
  • , Melroy X Miranda
  • , Christian M Matter
  • , Yuping Wu
  • , Lin Li
  • , Zeneng Wang
  • , Ha S Alamri
  • , Valentin Gogonea
  • , Yoon- M Chung
  • , W H Tang
  • , Stan L Hazen
  • Thomas F Lüscher

Research output: Contribution to journalArticle

Abstract

Systemic levels of trimethylamine N-oxide (TMAO), a pro-atherogenic and pro-thrombotic metabolite produced from gut microbiota metabolism of dietary trimethylamine (TMA)-containing nutrients such as choline or carnitine, predict incident cardiovascular event risks in stable primary and secondary prevention subjects. However, the prognostic value of TMAO in the setting of acute coronary syndromes (ACS) remains unknown.
Original languageEnglish
Number of pages11
JournalEuropean heart journal
Volume38
Issue number11
StatePublished - 2017

Cite this